Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Serum lactate as a novel potential biomarker in multiple sclerosis.
Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner.
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
Interferon-γ Activates Nuclear Factor-κ B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Vascular pathology of multiple sclerosis.
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Can the ABILHAND handle manual ability in MS?
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
Disease-specific molecular events in cortical multiple sclerosis lesions.
Age and the role of restricted activities in adjustment to disability related pain.
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.
The etiology of ring lesions on diffusion-weighted imaging.
Deep-brain stimulation for Parkinson's disease.
Features of sleep disturbances in multiple sclerosis patients.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.
Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
A salty taste to autoimmunity.
Pages
« first
‹ previous
…
308
309
310
311
312
313
314
315
316
…
next ›
last »